Literature DB >> 9596774

Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria.

V Fernandez1, C J Treutiger, G B Nash, M Wahlgren.   

Abstract

The cerebral form of severe malaria is associated with excessive intravascular sequestration of Plasmodium falciparum-infected erythrocytes (PRBC). Retention and accumulation of PRBC may lead to occlusion of brain microvessels and direct the triggering of acute pathologic changes. Here we report that by selection, cloning, and subcloning, we have identified rare P. falciparum parasites expressing a pan-adhesive phenotype linked to erythrocyte rosetting, a previously identified correlate of cerebral malaria. Rosetting PRBC not only bound uninfected erythrocytes but also formed autoagglutinates, adhered to endothelial cells, and bound to CD36, immunoglobulins, and the blood group A antigen. The linkage of rosetting, autoagglutination, and cytoadherence involved the coexpression on a single PRBC of ligands with multiple specificities and the binding to two or more receptors on erythrocytes and to at least two other cell adhesion molecules, including a new endothelial cell receptor for P. falciparum-infected erythrocytes. Limited proteolysis that differentially cleaved the rosetting ligand PfEMP1 from the PRBC surface abrogated all the binding phenotypes of these parasites, implicating the variant antigen PfEMP1 as a carrier of multiple ligand specificities. The results encourage the further study of pan-adhesion as a potentially important parasite phenotype in the pathogenesis of severe P. falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596774      PMCID: PMC108296          DOI: 10.1128/IAI.66.6.2969-2975.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes.

Authors:  J Carlson; G Holmquist; D W Taylor; P Perlmann; M Wahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria.

Authors:  C J Treutiger; I Hedlund; H Helmby; J Carlson; A Jepson; P Twumasi; D Kwiatkowski; B M Greenwood; M Wahlgren
Journal:  Am J Trop Med Hyg       Date:  1992-05       Impact factor: 2.345

Review 3.  Malarial proteins at the membrane of Plasmodium falciparum-infected erythrocytes and their involvement in cytoadherence to endothelial cells.

Authors:  R J Howard
Journal:  Prog Allergy       Date:  1988

4.  A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.

Authors:  J W Barnwell; A S Asch; R L Nachman; M Yamaya; M Aikawa; P Ingravallo
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

5.  Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum.

Authors:  A R Berendt; D L Simmons; J Tansey; C I Newbold; K Marsh
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

6.  Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1.

Authors:  C F Ockenhouse; M Ho; N N Tandon; G A Van Seventer; S Shaw; N J White; G A Jamieson; J D Chulay; H K Webster
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

7.  In vivo and in vitro derived Palo Alto lines of Plasmodium falciparum are genetically unrelated.

Authors:  T Fandeur; S Bonnefoy; O Mercereau-Puijalon
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

8.  Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies.

Authors:  J Carlson; H Helmby; A V Hill; D Brewster; B M Greenwood; M Wahlgren
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

9.  Multiple ligands for cytoadherence can be present simultaneously on the surface of Plasmodium falciparum-infected erythrocytes.

Authors:  S C Chaiyaroj; R L Coppel; S Novakovic; G V Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes.

Authors:  R Udomsangpetch; B Wåhlin; J Carlson; K Berzins; M Torii; M Aikawa; P Perlmann; M Wahlgren
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  35 in total

1.  An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.

Authors:  Inès Vigan-Womas; Micheline Guillotte; Cécile Le Scanf; Sébastien Igonet; Stéphane Petres; Alexandre Juillerat; Cyril Badaut; Farida Nato; Achim Schneider; Anne Lavergne; Hugues Contamin; Adama Tall; Laurence Baril; Graham A Bentley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

2.  Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.

Authors:  Marcele F Bastos; Letusa Albrecht; Eliene O Kozlowski; Stefanie C P Lopes; Yara C Blanco; Bianca C Carlos; Catarina Castiñeiras; Cristina P Vicente; Claudio C Werneck; Gerhard Wunderlich; Marcelo U Ferreira; Claudio R F Marinho; Paulo A S Mourão; Mauro S G Pavão; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

3.  Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum.

Authors:  S A Kyes; J A Rowe; N Kriek; C I Newbold
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum.

Authors:  A Scherf; R Hernandez-Rivas; P Buffet; E Bottius; C Benatar; B Pouvelle; J Gysin; M Lanzer
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

Review 5.  Molecular aspects of severe malaria.

Authors:  Q Chen; M Schlichtherle; M Wahlgren
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells.

Authors:  Alexander Luginbühl; Milica Nikolic; Hans Peter Beck; Mats Wahlgren; Hans U Lutz
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

7.  Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.

Authors:  Kirsten Moll; Fredrik Pettersson; Anna M Vogt; Cathrine Jonsson; Niloofar Rasti; Sanjay Ahuja; Mats Spångberg; Odile Mercereau-Puijalon; David E Arnot; Mats Wahlgren; Qijun Chen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  Identification of a polyclonal B-cell activator in Plasmodium falciparum.

Authors:  Daria Donati; Li Ping Zhang; Arnaud Chêne; Qijun Chen; Kirsten Flick; Maja Nyström; Mats Wahlgren; Maria Teresa Bejarano
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Optimal tumor necrosis factor induction by Plasmodium falciparum requires the highly localized release of parasite products.

Authors:  Kieran P O'Dea; Geoffrey Pasvol
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells.

Authors:  Qingfeng Chen; Anburaj Amaladoss; Weijian Ye; Min Liu; Sara Dummler; Fang Kong; Lan Hiong Wong; Hooi Linn Loo; Eva Loh; Shu Qi Tan; Thiam Chye Tan; Kenneth T E Chang; Ming Dao; Subra Suresh; Peter R Preiser; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.